Top Stories

Regeneron vows ‘vigorous’ defense against allegations it paid kickbacks for eye drug

Drugmaker Regeneron Pharmaceuticals has said it will “vigorously” defend against allegations by the Department of Justice that it paid kickbacks through a foundation in connection with a drug it markets for macular degeneration in order to cover Medicare beneficiaries’ copays. On Wednesday, the U.S. district attorney for Massachusetts filed suit against the Tarrytown, New York-based […]

Top Stories

Magenta, Beam partner to explore use of antibody-based conditioning drug for gene therapies

A company developing a drug to address the growing need for safe ways to condition patients receiving cell and gene therapies is partnering with a firm developing single letter-level gene editing to investigate ways to apply its approach in patients with blood disorders. Cambridge, Massachusetts-based Magenta Therapeutics and Beam Therapeutics said Monday that they had […]

Top Stories

Lilly drug for cancers with highly targetable genetic abnormality gets FDA nod

The Food and Drug Administration has granted accelerated approval to the latest in a growing group of cancer drugs designed to target genetic abnormalities with a high probability of producing a clinical effect. The agency granted the accelerated approval Friday to Indianapolis-based drugmaker Eli Lilly’s Retevmo (selpercatinib) for advanced non-small cell lung cancer (NSCLC) and […]

Top Stories

Trump: Dems Would Rather Let Coronavirus Patients Stay Sick Than Give Credit For Unproven Drug

President Donald Trump said without evidence on Sunday that his political opponents would rather see coronavirus patients not improve to avoid giving him credit for touting an unproven anti-malarial drug as a treatment option. Trump participated in a virtual town hall hosted by Fox News’ Bret Baier and Martha MacCallum at the Lincoln Memorial in […]

Top Stories

Chimerix starts Phase II/III trial of heparin-derived blood cancer drug in Covid-19

This illustration, created at the Centers for Disease Control and Prevention (CDC), reveals ultrastructural morphology exhibited by coronaviruses A company developing a drug derived from the blood thinner heparin for a form of leukemia is planning to test it in patients with Covid-19 due to its anti-inflammatory and anti-clotting properties. Durham, North Carolina-based Chimerix said […]